Similar articles

• [Current insights in the treatment of primary biliary cirrhosis].

  van Berge Henegouwen GP, Brandt KH, Schalm SW. van Berge Henegouwen GP, et al. Ned Tijdschr Geneeskd. 1978 Apr 22;122(16):548-50. Ned Tijdschr Geneeskd. 1978. PMID: 643111 Dutch. No abstract available.
• Primary biliary cirrhosis as a collagen disease.

  Schaffner F. Schaffner F. Postgrad Med. 1979 Jun;65(6):97-102. doi: 10.1080/00325481.1979.11715175. Postgrad Med. 1979. PMID: 377267 Review.
• Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis.

  Epstein O, De Villiers D, Jain S, Potter BJ, Thomas HC, Sherlock S. Epstein O, et al. N Engl J Med. 1979 Feb 8;300(6):274-8. doi: 10.1056/NEJM197902083000602. N Engl J Med. 1979. PMID: 759879 Clinical Trial.
• The treatment of primary biliary cirrhosis.

  Adams D, Clements D, Elias E. Adams D, et al. J Clin Hosp Pharm. 1986 Apr;11(2):65-73. doi: 10.1111/j.1365-2710.1986.tb00830.x. J Clin Hosp Pharm. 1986. PMID: 3519687 Review. No abstract available.
• Hepatic organelle pathology in primary biliary cirrhosis and the response to low-dose D-penicillamine therapy.

  Scott J, Jenkins W, Smith GP, Peters TJ. Scott J, et al. Clin Sci (Lond). 1981 Feb;60(2):207-12. doi: 10.1042/cs0600207. Clin Sci (Lond). 1981. PMID: 7237933